COMMUNIQUÉS West-GlobeNewswire

Zealand Pharma conference call on February 27 at 2pm CET (8am ET) to present full year 2023 financial results
20/02/2024
Press Release – No. 2 / 2024 Zealand Pharma conference call on February 27 at 2pm CET (8am ET) to present full year 2023 financial results Copenhagen, Denmark, February 20, 2024 – a Zealand Pharma A/S (CVR-no. 20045078 [...]
Philogen provides update on pre-planned interim analysis of the Phase III FIBROSARC trial investigating Onfekafusp alfa (L19TNF) in patients with first-line advanced or metastatic Soft Tissue Sarcoma
20/02/2024
FIBROSARC (NCT04650984) is a Phase III trial evaluating Onfekafusp alfa (L19TNF, also known as Fibromun) plus doxorubicin versus doxorubicin alone as front-line therapy for patients with advanced or metastatic Soft [...]
argenx Announces FDA Acceptance of Supplemental Biologics License Application with Priority Review for VYVGART Hytrulo in Chronic Inflammatory Demyelinating Polyneuropathy
20/02/2024
Prescription Drug User Fee Act (PDUFA) target action date is June 21, 2024 If approved, VYVGART ® Hytrulo will be the first neonatal Fc receptor (FcRn) blocker to treat CIDP February 20, 2024, 7:00 AM CET Amsterdam, the [...]
Opthea Appoints Arshad M. Khanani, MD, MA, FASRS, as Chief Medical Advisor
20/02/2024
Global retina expert joins to support sozinibercept development and launch preparation MELBOURNE, Australia, Feb. 19, 2024 (GLOBE NEWSWIRE) -- Opthea Limited (ASX:OPT; NASDAQ:OPT, “Opthea”), a clinical-stage [...]
Preparatory documents for the General Meeting as of of March 25, 2024
19/02/2024
Combined General Meeting of March 25, 2024 Availability of preparatory documents Spineway informs its shareholders that they are invited to attend the Combined General Meeting to be held on Monday, March 25, 2024 at 16: [...]
Documents préparatoires à l'Assemblée Générale du 25 Mars 2024
19/02/2024
Communiqué de presse Ecully, le 19 février 2024 – 18h Assemblée Générale Mixte du 25 mars 2024 Mise à disposition des documents préparatoires Spineway informe ses actionnaires qu’ils sont invités à participer à l’ [...]
GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 31 janvier 2024
19/02/2024
GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 31 janvier 2024 En application de l'article L. 233-8 II du code de commerce et de l'article 222-12-5 du règlement général de l'AMF, [...]
Novo Nordisk A/S – Share repurchase programme
19/02/2024
Bagsværd, Denmark, 19 February 2024 – On 6 February 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April [...]
Teladoc Health Provides Updated Start Time for Fourth Quarter 2023 Earnings Call on February 20, 2024
19/02/2024
PURCHASE, NY, Feb. 19, 2024 (GLOBE NEWSWIRE) -- Teladoc Health , Inc. (NYSE: TDOC), the global leader in whole-person virtual care, announced today that the conference call to review its fourth quarter 2023 results, [...]
Medigene to Present at Upcoming Conferences
19/02/2024
Planegg/Martinsried, February 19, 2024. Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an immuno-oncology platform company focusing on the discovery and development of T cell immunotherapies for [...]
BioCryst Launches ORLADEYO® (berotralstat) in Italy
19/02/2024
RESEARCH TRIANGLE PARK, N.C., Feb. 19, 2024 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the Italian Medicines Agency, Agenzia Italiana del Farmaco (AIFA), has finalized [...]
CMR Surgical hires industry leader to drive operations across Asia Pacific, the Middle East and Africa
19/02/2024
CMR Surgical hires industry leader to drive operations across Asia Pacific, the Middle East and Africa Sushobhan Dasgupta joins as President and Chief Commercial Officer for Asia Pacific, the Middle East and Africa [...]
Orion to investigate the possible outsourcing of its pharmaceutical production in Kuopio, Finland
19/02/2024
ORION CORPORATION PRESS RELEASE 19 FEBRUARY 2024 at 13:15 EET Orion to investigate the possible outsourcing of its pharmaceutical production in Kuopio, Finland Orion Corporation is evaluating the possible outsourcing of [...]
Transactions in connection with share buy-back program
19/02/2024
Company Announcement COPENHAGEN, Denmark; February 19, 2024 – Genmab A/S (Nasdaq: GMAB). On February 14, 2024, Genmab announced the initiation of a share buy-back program to honor our commitments under our Restricted [...]
New collaboration between Boehringer Ingelheim and Sleip leverages AI-technology to help detect lameness in horses
19/02/2024
The Sleip app uses artificial intelligence (AI) to provide objective analysis of a horse’s movement with just a smartphone. A new global commercial partnership between Boehringer Ingelheim and Sleip will expand access [...]
GN Store Nord A/S - Notice to convene the Annual General Meeting 2024
19/02/2024
GN Store Nord’s Annual General Meeting will be held on Wednesday, March 13, 2024, at 10:00 a.m. CET at the company’s address: Lautrupbjerg 7, 2750 Ballerup, Denmark. Please find attached the notice to convene the Annual [...]
Certa Therapeutics’ FT011 Granted US FDA Fast Track for the Treatment of Systemic Sclerosis
19/02/2024
MELBOURNE, Australia, Feb. 19, 2024 (GLOBE NEWSWIRE) -- Certa Therapeutics (Certa), a biotechnology company developing innovative precision therapies for patients with inflammatory and fibrotic diseases, today announces [...]
CMR Surgical hires industry leader to drive operations across Asia Pacific, the Middle East and Africa
19/02/2024
CMR Surgical hires industry leader to drive operations across Asia Pacific, the Middle East and Africa Sushobhan Dasgupta joins as President and Chief Commercial Officer for Asia Pacific, the Middle East and Africa [...]
BioPorto A/S to host investor meetings on 22 February 2024
19/02/2024
19 February 2024 News Release BioPorto A/S to host investor meetings on 22 February 2024 COPENHAGEN, DENMARK and BOSTON, Mass., 19 February 2024, BioPorto A/S (BioPorto or Company), an in vitro diagnostics company [...]

Pages